Equity
€1.5m ▼ 21.5%
SYOPA paid out €787,840 in dividends. That is 208% of the 2025 profit.
SYOPA
Lifetime
17 annual accounts with figures on one time axispeak €764,096 (2024)
€608,695▼ 20.3%
peak €620,150 (2024)
€378,184▼ 39.0%
peak €1.9m (2024)
€1.5m▼ 21.5%
€693,654▲ 5.8%
peak 0 FTE (2024)
0 FTE
Board3 names since 2012
2 directors and 1 other
Documentsfilings and deeds
10-07-202621 days before the deadline
2025abbreviated format
Gross margin from €764,096 to €608,695Result from €620,150 to €378,184Dividend €787,840Equity from €1.9m to €1.5mCash from €637,679 to €225,281
Key points
from the 2025 annual accountsResult
€378,184 ▼ 39.0%
The result fell in 2025 from €620,150 to €378,184.
Turnover
≈ €920,000 estimated
The abbreviated format states no turnover.
Liquidity
3.37 was 4.55 in 2024
Short-term debts rose from €479,803 to €546,347.
Filings
17 annual accounts since 2009
The last five annual accounts were filed 21 to 61 days before the end of the period.
Position in the sector
€378,184
Higher net result than 80% of companies in human health. Sector median €125,403 · 2,765 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 17,806 companies had the same profile as SYOPA has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,806 companies, not a prediction for SYOPA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0811804777
2 directors resigning, 2 reappointments
Resignations: and · Reappointments: (director) and (director) · General meeting of 14-07-2023 · Gazette deed
Reappointments: (director) and (director)
General meeting of 19-03-2022 · Gazette deed
Reappointment: (manager)
General meeting of 19-07-2019 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SYOPA Zoersel | €2.2m | €608,695 | 68.4% | 0 |
| MICRUROL Herentals | €2.3m | €646,637 | 89.3% | 0 |
| ANEVASC Dendermonde | €2.4m | €637,543 | 84.9% | 0 |
| DR. JORIS DE BONDT,CARDIOLOGIE Nijlen | €2.0m | €494,434 | 73.1% | 0 |
| Dr. C. De Meyere Schilde | €2.0m | €465,954 | 91.7% | 0 |
| RADIOLOGIE VAN RILLAER Antwerp | €2.9m | €658,156 | 15.0% | 0 |
| Dr. Matthias Desmet - Dr. Sofie Decock Bruges | €2.3m | €759,974 | 81.7% | 0 |
These companies have the same main activity as SYOPA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2m and €2.9m, founded between 2007 and 2013.
Official details
Source: KBO- Status
- Active since 19-05-2009Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.197.267.7542980 Zoersel, since 19-05-2009
- Financial year end
- 31 December
- Peppol
- Reachable since 23-12-2024
Annual accounts 2025
- €2.2m▼ 14.5%
- Filing
- Filed on 10-07-2026, 21 days before the end of the filing period
Insights on SYOPA
SYOPA files the abbreviated format. That format states no turnover. The gross margin rose from €128,763 in 2009 to €608,695 in 2025.
The balance sheet grew most from 2012 to 2014 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SYOPA
- What is the company number of SYOPA?
- The company number of SYOPA is 0811.804.777. The VAT number is the same number with BE in front: BE 0811.804.777.
- Where is SYOPA based?
- The registered office is at Jachthoornlaan 30, 2980 Zoersel.Company details
- What does SYOPA do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of SYOPA?
- SYOPA is a private limited company (BV).
- When was SYOPA founded?
- SYOPA was founded on 19-05-2009.
- Is SYOPA still active?
- Yes, SYOPA is an active enterprise in the KBO register.
- What is the turnover of SYOPA?
- The turnover in financial year 2025 is ≈ €920,000. This figure is estimated from the gross margin of €608,695 and 30 comparable companies (NACE 86220). It probably lies between €830,000 and €1.3m.Financials
- Is SYOPA profitable?
- In financial year 2025, SYOPA made a profit of €378,184.
- Where can I find the annual accounts of SYOPA?
- SYOPA filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SYOPA due?
- SYOPA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.